{
    "case_number": "CAC-UDRP-105806",
    "time_of_filling": "2023-09-26 09:43:49",
    "domain_names": [
        "hr-novartis.com"
    ],
    "case_administrator": "Olga Dvořáková (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "BRANDIT GmbH",
    "respondent": [
        "Wang Lao"
    ],
    "respondent_representative": null,
    "factual_background": "<p>The Novartis Group is one of the biggest global pharmaceutical and healthcare groups. It provides solutions to address the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs.&nbsp;<\/p>\n<p>The disputed domain name was registered on August 28, 2023. It does not resolve to an active website. MX servers are configured. The Respondent did not reply to a cease-and-desist letter from the Complainant.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.<\/p>\n<p>No administratively compliant Response has been filed.&nbsp;<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Alan Limbury"
    ],
    "date_of_panel_decision": "2023-10-27 00:00:00",
    "informal_english_translation": "<p>The Complainant has rights in the trademark NOVARTIS, through numerous registrations around the world, including in the United States, USPTO Reg. No. 2,336,960, registered on April 4, 2000.<\/p>",
    "decision_domains": {
        "hr-novartis.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}